Borderline BE study Failure [Study As­sess­ment]

posted by Samaya B – India, 2014-10-14 11:02 (3861 d 21:05 ago) – Posting: # 13696
Views: 8,337

Dear All,

For Product X (IR tablets), full replicated BE study was performed on 56 volunteers under fasting state (EU submission).

When data for first half subjects (N: 28) was analysed, we got following results.
Cmax ratio: 87 (CI: 80.88-95.13)
AUC ratio: 87 (CI: 81.85-94.18)

Analysis of full data set (N: 56)
Cmax ratio: 84.32 (CI: 79.89-89.00)
AUC ratio: 86.9 (CI: 83.02-90.96)

%ISCV Cmax: 25
%ISCV AUC: 20
Power ~100
No outlier detected.

Is there any possibility to get through by any means or study to be repeated?
Or we should go ahead with the reformulation??
PROC GLM is used for stat calculation

Kindly advice.
Thanks!

Regards,
Samaya.


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
142 visitors (0 registered, 142 guests [including 7 identified bots]).
Forum time: 08:07 CEST (Europe/Vienna)

Lack of clarity is always a sign of dishonesty.    Celia Green

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5